Increased number of nitric oxide synthase immunoreactive Purkinje cells and dentate nucleus neurons in schizophrenia

Journal of Neurocytology

Volumn 30, Issue 8, 2001, Pages 661-670

  Bernstein, H G ^a   Krell, D ^a   Braunewell, K H ^b,c   Baumann, B ^a   Gundelfinger, E D ^b   Diekmann, S ^a   Danos, P ^a   Bogerts, B ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b LEIBNIZ INSTITUTE FOR NEUROBIOLOGY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; CALCIUM SENSOR PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE SYNTHASE; PROTEIN VILIP 1; PROTEIN VILIP 3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CALCIUM SIGNALING; CELLULAR DISTRIBUTION; CEREBELLUM VERMIS; CONTROLLED STUDY; DENTATE NUCLEUS; DEPRESSION; ENZYME ACTIVITY; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; NERVE CELL DIFFERENTIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURKINJE CELL; SCHIZOPHRENIA;

ADULT; CALCIUM SIGNALING; CALCIUM-BINDING PROTEINS; CELL COUNT; CEREBELLAR NUCLEI; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NEUROCALCIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PURKINJE CELLS; RECEPTORS, CALCIUM-SENSING; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 0035427883     PISSN: 03004864     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016520932139     Document Type: Article

References (60)

1. Distorted distribution of nicotinamide-adenine dinucleotide phophate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development
2. A quantitative study of the human cerebellum with unbiased stereological techniques
3. Schizophrenia: The fundamental questions
4. "Cognitive dysmetria" as an intergrative theory of schizophrenia: A dysfunction in cortical-subcorticalcerebellar circuitry?
5. Antidepressant drug exposure is associated with mRNA levels of tyrosine receptor kinase B in major depressive disorder
6. Regional and cellular distribution of neural visinin-like protein immunoreactivities (VILIP-1 and VILIP-3) in human brain
7. Hippocampal expression of the calcium sensor protein VILIP-1 in schizophrenia
8. Nitric oxide synthase-containing neurons in the human hypothalamus: Reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics
9. On the effect of neonatal nitric oxide synthase inhibition in rat: A potential neurodevelopmental model of schizophrenia
10. Characterization tion and regional distribution of nitric oxide synthase in the human brain during normal ageing
11. Intracellular neuronal sensor (NCS) protein VILIP-1 modulates cGMP signalling pathways in transfected neural cells NOS-containing cerebellar neurons in schizophrenia and cerebellar granule neurons
12. Abnormal localization of two neuronal calcium sensor proteins, visinin-like proteins (VILIPs)-1 and -3, in neocortical brain areas of Alzheimer disease patients
13. Association of the CACN1A4 (SCA6) triplet repeat arm with schizophrenia
14. Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain
15. Application of [3H]L-N(G)-nitro-arginine labelling to measure cerebellar nitric oxide synthase in patients with schizophrenia
16. Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses
17. Expression of serotonin 5-HAT (A) receptors in the human cerebellum and alterations in schizophrenia
18. The distribution of nitric oxide synthase immunoreactivity in the human brain
19. Detecting structural changes in whole brain based on nonlinear deformations - Application to schizophrenia research
20. 3H] LNω-nitro-arginine autoradiography
21. Cerebellar vermis atrophy in psychiatric patients
22. Evaluation of superior vermal Purkinje cell placement in mental illness
23. The regulatory connection between the activity of granule cell NMDA receptors and dendritic differentiation of cerebellar Purkinje cells
24. Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry
25. Clinical subtyping reveals significant differences in calcium-dependent phopspholipase A2 activity in schizophrenia
26. Reduced volume of the cerebellar vermis in neuroleptic-naive schizophrenia
27. A decrease of reelin expression as a putative vulnerability factor in schizophrenia
28. Nitric oxide synthase (NOS) in schizophrenia: Increases in cerebellar vermis
29. Neuropathology of the cerebellum in schizophrenia - An update: 1996 and future directions
30. Regional neural dysfunctions in chronic schizophrenia studied by positron emission tomography
31. Exploration of signal transduction pathways in cerebellar long-term depression by kinetic stimulation
32. Increased levels of transcription factors Elk-1, cyclic adenosine monophosphate response element-binding protein, and activating transcription factor 2 in the cerebellar of schizophrenic patients
33. Morphometry of individual cerebellar lobules in schizophrenia
34. Cerebellar pathology in schizophrenia? A neuronometric study
35. Cerebellum and schizophrenia: A selective review
36. Visinin-like protein (VILIP) is a neuron-specific calcium-dependent double-stranded RNA-binding protein
37. Anatomic evidence for cerebellar and basal ganglia involvement in higher cognitive function
38. Basal ganglia and cerebellar loops: Motor and cognitive circuits
39. Subdural applications of NO scaenger or NO blocker to the cerebellum depress the adaptation of monkey post-saccadic smooth pursuit eye movements
40. Cerebellar atrophy in schizophrenia and mania
41. Developmental characteristics of neuronal nitric oxide synthase (nNOS) immunoreactive neurons in fetal to adolescent human brains
42. Histochemistry of guanylate cyclase, phosphodiesterase, and NADPH-diaphorase (nitric oxide synthase) in rat brain vasculature
43. Comparative pharmacology of bipolar disorder and schizophrenia
44. Cerebellar vermis in schizophrenia
45. Neuronal and inducible nitric oxide synthase and nitration after oxygen and glucose deprivation
46. Mid-sagittal anatomy in late-onset schizophrenia
47. The cerebellar cognitive affective syndrome
48. Cerebellar functional abnormalities in schizophrenia are suggested by classical eyeblink conditioning
49. Abnormal persistence of cerebellar serotonin-1A receptors in schizophrenia suggests failure of regress in neonates
50. Neurology and neuropathology of schizophrenia
51. Contribution of alcohol abuse to cerebellar volume deficits in schizophrenia
52. Cerebellar vermis area in schizophrenic patients - A postmortem study
53. Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients
54. Amyloid precursor proteins in the cerebellar cortex of Alzheimer's disease patients devoid of cerebellar β-amyloid deposits: Immunocytochemical study of five cases
55. Reduced Purkinje cell size in the cerebellar vermis of elderly schizophrenics
56. Nitric oxide and synaptic plasticity: NO news from the cerebellum
57. Über die entwicklungsstörungen der purkinjezellen
58. Cerebellar morphology as a predictor of symptoms and psychosocial outcome in schizophrenia
59. Cerebellar pathology in schizophrenia: A controlled postmortem study
60. Spatial periodicity of NADPH-diaphorase and synaptophysin, but not SNAP-25, reactivity in the monkey cerebellar cortex